Albany Molecular Research (AMRI) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Contract revenue: 151.68M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Contract revenue: 151.68M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $163.8 million versus the consensus estimate of $161.45 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
